Next Article in Journal
China’s Land Uses in the Multi-Region Input–Output Framework
Next Article in Special Issue
Electrophysiological Correlates of an Alcohol-Cued Go/NoGo Task: A Dual-Process Approach to Binge Drinking in University Students
Previous Article in Journal
Evaluation of Policies on Inappropriate Treatment of Dead Hogs from the Perspective of Loss Aversion
Previous Article in Special Issue
A Multilevel Study of Alcohol Consumption in Young Adults: Self-Efficacy, Peers’ Motivations and Protective Strategies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Heavy Drinking and Non-Medical Use of Prescription Drugs among University Students: A 9-Year Follow-Up

1
Department of Public Health, Universidade de Santiago de Compostela, Santiago de Compostela 15782, Spain
2
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid 28029, Spain
3
Department of Clinical Psychology and Psychobiology, Universidade de Santiago de Compostela, Santiago de Compostela 15782, Spain
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2019, 16(16), 2939; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph16162939
Submission received: 10 July 2019 / Revised: 10 August 2019 / Accepted: 11 August 2019 / Published: 16 August 2019
(This article belongs to the Special Issue Alcohol Use Among Adolescents and Young People)

Abstract

:
Purpose: Investigations suggest non-medical use of prescription drugs (NMUPD) is associated with heavy drinking and polydrug use among university students. Our aim is to determine the prevalence of NMUPD among university students and to analyze its association with alcohol, tobacco, and cannabis use, and to study the role of the age of drinking onset. Methods: Cohort study among university Spanish students (n = 1382). Heavy drinking (HED) and risky consumption (RC) were measured with the Alcohol Use Disorders Identification Test. Questions related to tobacco and cannabis consumption were also formulated. NMUPD refers to sedative, anxiety, or pain medication intake within the last 15 days without medical prescription. All variables were measured at 18, 20, and 27 years. Multilevel logistic regression for repeated measures was used to obtain adjusted OR (odds ratios). We analyzed the results from a gender perspective. Results: Prevalence of NMUPD were higher in students who already partook in NMUPD at the beginning of the study. NMUPD in women at 27 is 3 times higher than at 18, while in men it is twice. Among females, RC (OR = 1.43) and cannabis consumption (OR = 1.33) are risk factors for NMUPD, while later onset of alcohol use (OR = 0.66) constitutes a protective factor. No significant differences were found for males. Conclusions: NMUPD is prevalent among university students. RC and early onset of alcohol use were associated with higher prevalence of NMUPD in females. The prevalence of NMUPD increased with age in both sexes. Strategies for reducing risky drinking and delaying onset of drinking should be provided for university students. Pharmacists and parents should be alerted to the risk of NMUPD.

1. Introduction

Substance abuse in young people is a serious public health concern, especially in regard to cannabis and highly prevalent forms of alcohol risky consumption such as heavy episodic drinking [1,2]. Abuse of these substances has been associated with neurocognitive alterations in the still developing young brain [3,4] and also with other major social problems such as traffic accidents and unsafe sex [5,6].
In the last few years, pharmacoepidemiological studies involving university students have shown that the non-medical use of prescription drugs (NMUPD) is common in this population [7,8,9,10]. NMUPD has increased steadily among young people in the last decade (usually linked to self-treatment, experimentation, and readily accessibility), and the consequent incidence of unintentional overdoses has reached epidemic levels [11,12,13]. In addition, NMUPD is a risk factor for suicide [14,15], negative sexual behavior [16,17], and poor social functioning [18].
Recent studies indicate that NMUPD is associated with heavy drinking, alcohol problems, and polydrug use (e.g., including cannabis) [19,20,21]. In other studies, students who engaged in heavy drinking were between three and four times more likely to report NMUPD [19,20]. Similarly, in Spain, several studies have shown that high consumption of both medically prescribed and non-prescription medicines is associated with consumption of alcohol, tobacco, and cannabis among young people [22,23,24].
The epidemiological data on the association between NMUPD and alcohol, tobacco, and cannabis use among college students in Europe remains insufficient to date. Indeed, the lack of longitudinal studies hampers analysis of the changes in this association in the important developmental period between adolescence and adulthood, in which a decline in heavy drinking is expected [25]. Another aspect given little attention is the role of the age of drinking onset in this relationship, which given the tendency for young people to start drinking alcohol at an early age- deserves further attention in the context of NMUPD [6]. Findings regarding sex-related differences and this association are inconsistent, which may be partly explained by differences in the populations investigated, with some studies reporting a greater risk in females and others in males [26]. This is of particular importance considering that females may be particularly vulnerable to the long-term consequences of alcohol abuse [27]. Furthermore, accessibility, a key explanatory factor for the use of medical drugs, varies significantly between countries [9]. Further epidemiological studies are thus necessary to enable context-dependent conclusions to be drawn and transcultural extrapolations to be made. Ultimately, addressing these gaps may have important implications for public health prevention strategies by improving their focus.
The aim of this study was to determine the prevalence of NMUPD among university students in Spain and to analyze the association between NMUPD and the most prevalent patterns of alcohol, tobacco, and cannabis consumption among young adults, as well as the explanatory role of the age of drinking onset. We investigated this relationship by following the longitudinal trajectories of consumption in both males and females during the transition to adulthood. We also examined the potential variations in the long-term patterns of consumption in relation to whether or not the participants already partook in NMUPD at the beginning of the study, separately for males and females.

2. Materials and Methods

2.1. Design, Population, and Sample

We carried out a cohort study among university students (Compostela Cohort 2005, Spain), between November 2005 and February 2015. We used cluster sampling to select the participants. Thus, at least one of the first-year classes was randomly selected from each of the 33 university faculties/schools (a total of 53 classes). The number of classes selected in each university faculty or school was proportional to the number of students. All students present in the class on the day of the survey were invited to participate in the study (n = 1382). This study was approved by the Bioethics Committee of the University of Santiago de Compostela. Subjects were informed both verbally and in writing, as part of the questionnaire, that participation was voluntary, anonymous, and the possibility to opt-out was available at any time.

2.2. Data Collection Procedures

Researchers visited each first-year classroom in November 2005 and invited all students present in the class to participate in the study. Participants were evaluated via a self-administered questionnaire in the same classroom (1st questionnaire). In November 2007, the same team of researchers visited the third-year classroom in order to follow-up with the students. Participants were re-evaluated via a self-administered questionnaire (2nd questionnaire). The questionnaires were linked using birth date, sex, school, and class. Students who provided a phone number in the first or second questionnaire were further evaluated by phone after 9.0 years (March 2015). On all three occasions, alcohol use was measured with the Galician validated version of the Alcohol Use Disorders Identification Test (AUDIT) [28,29]. In addition to the AUDIT, we used another questionnaire that asked about age of onset of alcohol use, tobacco, and cannabis consumption, and use of medicines. The subjects were asked about their use of different medicines, with and without prescription, during the previous 15 days, using the Spanish National Health Survey [30]. More details about data collection are available in the following references [22,31].

2.3. Definition of Variables

2.3.1. Independent Variables

Heavy drinking: Dichotomous variable generated from the third AUDIT [28] question “How often do you have 6 or more alcoholic drinks per occasion?”, which was coded as follows: Never = 0, less than once a month = 0, once a month = 1, once a week = 1, daily or almost daily = 1. The sensitivity and specificity of this question with this cut-off value are respectively 0.72 and 0.73, and the area under the curve is 0.767 (95% CI: 0.718–0.816) [32].
Risky consumption: This (dichotomous) variable was generated from the AUDIT [28] score. A different cut-off value was established according to gender: ≥5 for women; and ≥6 for men. These cut-offs are recommended in the Galician validated version of the AUDIT [29].
Age of onset of alcohol consumption: Four categories were defined (after 16 years old, at 16, at 15, before the age of 15).
Cannabis consumption: Measured with the question “Do you consume cannabis when you go out? Never; Sometimes; Most of the times; Always” at the beginning of the study and at 2 years of follow-up. The categories were recategorized into No (“never”) and Yes (“sometimes”, “most of the time”, and “always”). At 9 years of follow up, cannabis consumption was measured using the European Addiction Severity Index (EuropASI) [33].
Tobacco consumption: Measured as a dichotomous variable: No/Yes at the beginning of the study and at 2 years of follow-up. At 9 years of follow up, we also used the European Addiction Severity Index (EuropASI) [33].

2.3.2. Dependent Variable

Non-medical use of prescription drugs (NMUPD): Categorized as a dichotomous variable (“YES” refers to have taken sleeping medication/sedative or anxiety medication/stimulant medication/or pain medication in the past 15 days without medical prescription; and “NO” refers to the other cases. NMUPD criteria were adapted from those used by Boyd and colleagues [34].

2.4. Statistical Analysis

We used repeated measures multilevel logistic regression to obtain the adjusted odds ratios (OR) for independent variables in the use of medicines models. The 95% confidence intervals (95% CI) were calculated. These models are more flexible than traditional models and therefore allow us to work with correlated data, as we potentially have three measures of the same subject. Maximal models were generated, including all theoretical independent variables. Final models were generated from these maximal models. The final models included all significant variables or non-significant variables when their exclusion changed the OR of other variables by more than 10%. Data were analyzed using generalized linear mixed models in SPSS v.20 statistical software.

3. Results

The description of the samples at the beginning of the study for women and men are summarized in Table 1. There were no significant differences between samples for any variables.
The prevalence of risky consumption, heavy drinking, tobacco consumption, and cannabis consumption at baseline and after 2 years and 9 years are shown in Table 2. There was a significant reduction in the consumption of all substances and the specific patterns of consumption in the intervening period.
The proportion of NMUPD in relation to age of onset of alcohol use, risky consumption, heavy drinking, cannabis, and tobacco use at the ages of 18, 20, and 27 years is shown in Table 3. In general, the prevalence of NMUPD was greater among drug users (cannabis, tobacco, risky consumption, and heavy drinkers) than among non-users (tobacco use at age 20 for males whereas for females at age 18 risky consumption, heavy drinking, and cannabis; at age 20 risky consumption and cannabis, and at 27 risky consumption and tobacco). The prevalence of NMUPD was highest in females with risky alcohol consumption (Table 3) and tended to increase over time. In addition, the prevalence of NMUPD was higher in females who started to consume alcohol before the age of 15 than in those who began consuming alcohol after this age.
The trends in the prevalence of NMUPD during the study period for students who had consumed and students had not consumed NMUPD at the beginning of the study are shown in Figure 1 (females) and Figure 2 (males). The prevalence rates were higher throughout the study in students who already partook in NMUPD at the beginning of study in both males and females. The prevalence of NMUPD was higher in both groups (already users or not) in both sexes in early adulthood (27–28 years old). At age 27 the difference between those who started university already partaking in NMUPD and those who did not partake in NMUPD was 22.4 percent points for females (see Figure 1) and 9.3 percent points for males (see Figure 2). Prevalence among those who practice NMUPD and those who do not were statistically significant among women at all ages (Figure 1) but were not among men (Figure 2).
Among females, the multivariate logistic regression models showed that risky alcohol consumption (OR = 1.43) and cannabis consumption (OR = 1.33) are risk factors for NMUPD. Later onset of alcohol use (at 16 OR = 0.63; after 16 OR = 0.66) constitutes a protective factor. Finally, the bivariate analysis revealed that a high frequency of heavy drinking is also associated with NMUPD (OR = 1.38). (Table 4).
Among males, there was no association between substance use or the age of drinking onset and NMUPD. The statistical models were rerun without including the stimulants medication for both sexes, and the findings did not differ. The final model also showed that the risk of consuming NMUPD increases with age in both sexes. The risk of incidence of NMUPD in women at age 27 is three times the risk at age 18 years, whereas in men the risk is twice as high for the same ages (Table 4).

4. Discussion

The aim of this study was to determine the longitudinal prevalence of NMUPD during the transition to adulthood in university students—taking gender into account—and how NMUPD is associated with patterns of tobacco, cannabis, and alcohol use (heavy drinking and risky consumption) and the effect of early drinking onset. The findings indicate that cannabis use and, in particular, risky alcohol consumption are risk factors for NMUPD among female students. Early onset of alcohol use was also a risk factor for NMUPD in females. However, no such association was found in males. Additionally, NMUPD was significantly higher at the age of 27, in both males and females.
Overall, the data revealed a high prevalence of NMUPD among the university students. Evidence from several studies has shown that non-medically prescribed drugs are readily accessible to young people, and the main sources seem to be family and friends [12,35,36,37]. The following reasons are often given to explain this type of drug abuse: For self-realization and recreational purposes, for relieving pain and anxiety, for combatting depression and for alleviating sleep-related problems [8,17,38]. Another context-dependent factor is that pharmacists do not seem to demand medical prescriptions from younger and/or more educated customers, such as university students [39].
Regarding sex-related effects, we observed striking differences between males and females. In males there was no association between substance use and NMUPD. On the contrary, in women, NMUPD is associated with risky consumption of alcohol (even heavy drinking in bivariate analysis). Risky drinking seems to be transculturally associated with NMUPD in young people [19,21,40,41,42,43]. Although some studies have reported a higher prevalence of NMUPD in males, many studies have indicated that females are at a greatest risk [9,26], (for a systematic review, see Young et al., 2012 [44]). Such differences may vary depending on the drugs investigated, the characteristics of the sample and the dose/frequency of drug use [26], although further studies are needed for confirmation. Excessive alcohol consumption may lead to dysregulation of the stress response, particularly in females [27], which hypothetically may contribute to a maladaptive coping style including the self-prescribed use of non-medically prescribed drugs to deal with emotional distress (as self-medication seems to be the most common motive in females [26] during adolescence). In addition to the cognitive alterations (e.g., memory deficits) that result from risky drinking during young adulthood, the possible interactions between these substances—together with the cognitive impairments associated with NMUPD [45]—may lead both to greater reinforcement of their addictive potential and to serious medical consequences [46,47].
Although higher prevalence of NMUPD among female cannabis users was found at the ages of 18 and 20, this did not translate onto an effect at the bivariable of multivariable analysis. This lack of association does not go in line with other authors’ results [19,20,21]. On the other hand, the lack of significant differences among NMUPD prevalence of female students who consume vs. do not consume cannabis at the age of 27 may be explained by the lower prevalence of cannabis consumption at this age—an association which may be difficult to find if it existed.
Another variable which presented higher NMUPD prevalence among users, but did not show influence at the analyses, was tobacco consumption. Unlike other studies in our context found in scientific literature [22,23,24], tobacco use was not associated with NMUDP among college students, regardless of their gender.
The lack of association of the consumption of these two substances with the NMUPD among university students should be studied in more depth. Future studies in our context should confirm or not these results, as well as look for possible explanations to them, since understanding not only what influences, but what does not influence NMUPD, allows the problem to be approached from a more effective perspective.
Our findings show how earlier age onset of alcohol consumption seems to increase the risk of practicing NMUPD. It is possible that some other factor is influencing this association, such as a predisposition to substance use, stress, or a certain personality, or even some combination of all of them. Having witnessed significant violence, suffering post-traumatic stress disorders, or having previous delinquent behaviors, having problems with family and friends, or having recent social environmental stressors have been related to NMUPD in university students by other authors, but further studies are necessary to support these hypotheses [48,49]. Nevertheless, delaying the age of drinking onset as a protective factor, has been previously referred in scientific literature [41,50]. Multiple hypotheses have been proposed to explain this association (e.g., the “gateway” hypothesis, the “common-model factor”) [51,52]. However, testing of these hypotheses is hampered by the lack of prospective studies beginning before drinking onset. This result adds support to a large body of literature highlighting the risks associated with early age onset of drinking, such as future psychopathological symptoms and alcohol dependence [53,54,55].
With respect to age-related changes, the prevalence of NMUPD in early adulthood (27 years) was higher than at younger ages (18 years) in both sexes, as also indicated in the Spanish National Health survey [30]. In females, the risk of NMUPD was three times higher at age 27 years than at age 18 years, and in men the risk was two times higher for the same ages. It is possible that NMUPD may increase with age [26], although few studies have covered the period of emerging adulthood. The fact that NMUPD increased throughout the study while other substance use decreased may be related to common transitions in social roles. Risky alcohol use in young people usually peaks during university years and decreases thereafter, probably due to the abandonment of the “campus alcohol culture” (peer pressure, availability/opportunity, normalization, etc.) and the acquisition of new adult roles linked to greater responsibilities, work, and family [31,56]. Conversely, greater social acceptance of NMUPD in adulthood and misconceptions about the safety of the drugs involved may partly explain the longitudinal trends observed in this study [57,58].
In this epidemiological study, a great effort was made to follow a large cohort of university students over a nine-year period. Nonetheless, the study is not without limitations. First, the use of self-reported questionnaires may lead to misrepresentation (under or over estimation) of the problem [59]. However, this type of test has been shown to produce reliable results when used with young adults and adolescents [60], and any misrepresentative results would probably affect descriptive rather than analytical findings [61]. Secondly, the loss of subjects over the follow-up period is a problem inherent to longitudinal designs and may lead to selection bias. However, the absence of significant differences between the initial sample and the follow-up sample suggests the lack of such bias.

5. Conclusions

NMUPD is prevalent among university students. Risky alcohol consumption and early onset alcohol use were associated with a higher prevalence of NMUPD in females, whereas no such association was found in males. The prevalence of NMUPD increased with age in both sexes. Prevention efforts should aim to educate university students regarding the potential effects of these drugs and their interactions. Strategies for handling stress during the university period should also be provided, with greater emphasis on females. In addition, pharmacists and parents should be alerted to the risk of NMUPD. Finally, the present study highlights the protective effect of delaying the age of drinking onset, beyond the typical alcohol-related problems.

Author Contributions

F.C.-I., F.C., M.C. and S.R.-H. have designed the study. F.C.-I., F.C., M.C. and L.M.-R. have analyzed and interpreted data. A.B.M., F.C.-I., L.M.-R. and A.D.-G. have written the article. All authors have approved the final version for publication.

Funding

Funding for this study was provided by the Plan Nacional sobre Drogas (Spain) (2005/PN014) and the Fondo de Investigación Sanitaria (Spain) (PI15/00165).

Acknowledgments

We are grateful to the Department of Public Health and the Department of Clinic Psychology and Psychobiology of USC. And to the students.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. ESPAD Group. ESPAD Report 2015: Results from the European School Survey Project on Alcohol and Other Drugs; The European Monitoring Center for Drugs and Drug Addiction (EMCDDA): Luxembourg, 2016; Available online: http://www.espad.org/sites/espad.org/files/ESPAD_report_2015.pdf (accessed on 5 July 2019).
  2. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The 2011 ESPAD Report: Substance Use among Students in 36 European Countries; The Swedish Council for Information on Alcohol and other Drugs (CAN): Stockholm, Sweden, 2012; Available online: http://www.espad.org/sites/espad.org/files/The_2011_ESPAD_Report_FULL_2012_10_29.pdf (accessed on 5 July 2019).
  3. Cservenka, A.; Brumback, T. The burden of binge and heavy drinking on the brain: Effects on adolescent and young adult neural structure and function. Front. Psychol. 2017, 8, 1111. [Google Scholar] [CrossRef] [PubMed]
  4. Silveri, M.M.; Dager, A.D.; Cohen-Gilbert, J.E.; Sneider, J.T. Neurobiological signatures associated with alcohol and drug use in the human adolescent brain. Neurosci. Biobehav. Rev. 2016, 70, 244–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Benotsch, E.G.; Martin, A.M.; Koester, S.; Mason, M.J.; Jeffers, A.J.; Snipes, D.J. Driving under the influence of prescription drugs used nonmedically: Associations in a young adult sample. Subst. Abus. 2015, 36, 99–105. [Google Scholar] [CrossRef] [PubMed]
  6. Marshall, E.J. Adolescent alcohol use: Risks and consequences. Alcohol Alcohol. 2014, 49, 160–164. [Google Scholar] [CrossRef] [PubMed]
  7. Collins, D.; Abadi, M.H.; Johnson, K.; Shamblen, S.; Thompson, K. Non-medical use of prescription drugs among youth in an Appalachian population: Prevalence, predictors, and implications for prevention. J. Drug Educ. 2011, 41, 309–326. [Google Scholar] [CrossRef] [PubMed]
  8. Drazdowski, T.K. A systematic review of the motivations for the non-medical use of prescription drugs in young adults. Drug Alcohol Depend. 2016, 162, 3–25. [Google Scholar] [CrossRef]
  9. Nargiso, J.E.; Ballard, E.L.; Skeer, M.R. A systematic review of risk and protective factors associated with nonmedical use of prescription drugs among youth in the United States: A social ecological perspective. J. Stud. Alcohol Drugs 2015, 76, 5–20. [Google Scholar] [CrossRef] [PubMed]
  10. Lipari, R.N.; Williams, M.; Van Horn, S.L. National Survey on Drug Use and Health (NSDUH), 2013–2017. Why Do Adults Misuse Prescription Drugs? In The CBHSQ Report; Substance Abuse and Mental Health Services Administration: Rockville, MD, USA, 2017. [Google Scholar]
  11. Boyd, C.J.; Cranford, J.A.; McCabe, S.E. Longitudinal trajectories of non-medical use of prescription medication among middle and high school students. J. Addict. Dis. 2016, 35, 258–265. [Google Scholar] [CrossRef] [Green Version]
  12. Novak, S.P.; Hakansson, A.; Martinez-Raga, J.; Reimer, J.; Krotki, K.; Varughese, S. Non medical se of prescription drugs in the European Union. BMC Psychiatry 2016, 16, 274. [Google Scholar] [CrossRef]
  13. Tapscott, B.E.; Schepis, T.S. Non medical use of prescription medications in young adults. Adolesc. Med. State Art Rev. 2013, 24, 597–610. [Google Scholar]
  14. Divin, A.L.; Zullig, K. The association between non-medical prescription drug use and suicidal behavior among United States adolescents. AIMS Public Health 2014, 1, 226–240. [Google Scholar] [CrossRef] [PubMed]
  15. Guo, L.; Xu, Y.; Deng, J.; Huang, G.; Gao, X.; Wu, H.; Pau, S.; Zang, W.H.; Lu, C. Association between nonmedical use of prescription drugs and suicidal behavior among adolescents. JAMA Pediatr. 2016, 170, 971–978. [Google Scholar] [CrossRef] [PubMed]
  16. Clayton, H.B.; Lowry, R.; Basile, K.C.; Demissie, Z.; Bohm, M.K. Physical and Sexual Dating Violence and Nonmedical Use of Prescription Drugs. Pediatrics 2017, 140, e20172289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Parks, K.A.; Levonyan-Radloff, K.; Przybyla, S.M.; Darrow, S.; Muraven, M.; Hequembourg, A. University student perceptions about the motives for and consequences of non-medical use of prescription drugs (NMUPD). J. Am. Coll Health 2017, 65, 457–465. [Google Scholar] [CrossRef] [PubMed]
  18. Tucker, J.S.; Ewing, B.A.; Miles, J.N.V.; Shih, R.A.; Pedersen, E.R.; D’Amico, E. Predictors and consequences of prescription drug misuse during middle school. Drug Alcohol Depend. 2015, 156, 254–260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Papp, L.M.; Kouros, C.D. Predicting young adults’ risk for engaging in prescription drug misuse in daily life from individual, partner, and relationship factors. Subst. Abus. 2017, 38, 61–68. [Google Scholar] [CrossRef] [PubMed]
  20. McCabe, S.E.; Veliz, P.; Patrick, M.E. High-intensity drinking and nonmedical use of prescription drugs: Results from a national survey of 12th grade students. Drug Alcohol Depend. 2017, 178, 372–379. [Google Scholar] [CrossRef] [PubMed]
  21. Silvestri, M.M.; Knight, H.; Britt, J.; Correia, C.J. Beyond risky alcohol use: Screening non-medical use of prescription drugs at National Alcohol Screening Day. Addict. Behav. 2015, 43, 25–27. [Google Scholar] [CrossRef] [PubMed]
  22. Caamaño-Isorna, F.; Mota, N.; Crego, A.; Corral, M.; Rodríguez-Holguín, S.; Cadaveira, F. Consumption of medicines, alcohol, tobacco and cannabis among university students: A 2-year follow-up. Int. J. Public Health 2011, 56, 247–252. [Google Scholar] [CrossRef] [PubMed]
  23. Carrasco-Garrido, P.; de Andrés, A.L.; Barrera, V.H.; Jiménez-Trujillo, I.; Fernandez-de-Las-Peñas, C.; Palacio-Ceña, D.; García-Gómez-Heras, S.; Jiménez-García, R. Predictive factors of self-medicated analgesic use in Spanish adults: A cross-sectional national study. BMC Pharm. Toxicol. 2014, 8, 15–36. [Google Scholar] [CrossRef]
  24. Morales-Suárez-Varela, M.; Llopis-González, A.; Caamaño-Isorna, F.; Gimeno-Clemente, N.; Ruiz-Rojo, E.; Rojo-Moreno, L. Adolescents in Spain: Use of medicines and adolescent lifestyles. Pharm. World Sci. 2009, 31, 656–663. [Google Scholar] [CrossRef] [PubMed]
  25. O’malley, P.M. Maturing out of problematic alcohol use. Alcohol Res. Health 2004, 28, 202–204. Available online: https://pubs.niaaa.nih.gov/publications/arh284/202-204.htm (accessed on 5 July 2019).
  26. Shehnaz, S.I.; Agarwal, A.K.; Khan, N. A systematic review of self-medication practices among adolescents. J. Adolesc. Health 2014, 55, 467–483. [Google Scholar] [CrossRef] [PubMed]
  27. Retson, T.A.; Sterling, R.C.; Van Bockstaele, E.J. Alcohol-induced dysregulation of stress-related circuitry: The search for novel targets and implications for interventions across the sexes. Prog. Neuropsychopharm. Biol. Psychiatry 2016, 65, 252–259. [Google Scholar] [CrossRef] [PubMed]
  28. Saunders, J.B.; Aasland, O.G.; Babor, T.F.; de la Fuente, J.R.; Grant, M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993, 88, 791–804. [Google Scholar] [CrossRef] [PubMed]
  29. Varela, J.; Braña, T.; Real, E.; Rial, A. Validation of AUDIT for Galician Population; Consellería de Sanidad-Sergas: Xunta de Galicia, Santiago de Compostela, Spain, 2005. [Google Scholar]
  30. Instituto Nacional de Estadística (INE). Spanish Nacional Health Survey 2003. Available online: https://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2003/home.htm (accessed on 6 July 2019).
  31. Moure-Rodríguez, L.; Piñeiro, M.; Corral-Varela, M.; Rodríguez-Holguín, S.; Cadaveira, F.; Caamaño-Isorna, F. Identifying predictors and prevalence of alcohol consumption among university students: Nine years of follow-up. PLoS ONE 2016, 11, e0165514. [Google Scholar] [CrossRef]
  32. Tuunanen, M.; Aalto, M.; Seppä, K. Binge drinking and its detection among middle-aged men using AUDIT, AUDIT-C and AUDIT-3. Drug Alcohol Rev. 2007, 26, 295–299. [Google Scholar] [CrossRef]
  33. Kokkevi, A.; Hartgers, C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur. Addict. Res. 1995, 1, 208–210. [Google Scholar] [CrossRef]
  34. Boyd, C.J.; McCabe, S.E.; Cranford, J.A.; Young, A. Prescription drug abuse and diversion among adolescents in a southeast Michigan school district. Arch. Pediatr. Adolesc. Med. 2007, 161, 276–281. [Google Scholar] [CrossRef]
  35. McCabe, S.E.; Teter, C.J.; Boy, C.J. Illicit use of prescription pain medication among college students. Drug Alcohol Depend. 2005, 77, 37–47. [Google Scholar] [CrossRef]
  36. Meisel, M.K.; Goodi, A.S. Predicting prescription drug misuse in college students’ social networks. Addict. Behav. 2015, 45, 110–112. [Google Scholar] [CrossRef] [PubMed]
  37. Ross-Durow, P.L.; McCabe, S.E.; Boyd, C.J. Adolescents’ access to their own prescription medications in the home. J. Adolesc. Health 2013, 53, 260–264. [Google Scholar] [CrossRef] [PubMed]
  38. Moure-Rodríguez, L.; Doallo, S.; Juan-Salvadores, P.; Corral, M.; Cadaveira, F.; Caamaño-Isorna, F. Heavy episodic drinking, cannabis use and unsafe sex among university students. Gac. Sanit. 2016, 30, 438–443. [Google Scholar] [CrossRef] [PubMed]
  39. Caamaño-Isorna, F.; Tomé-Otero, M.; Takkouche, B.; Figueiras, A. Factors related with prescription requirement to dispense in Spain. Pharmacoepide. Drug Saf. 2004, 13, 405–409. [Google Scholar] [CrossRef] [PubMed]
  40. Ford, J.A.; Arrastia, M.C. Pill-poppers and dopers: A comparison of non-medical prescription drug use and illicit/street drug use among college students. Addict. Behav. 2008, 33, 934–941. [Google Scholar] [CrossRef] [PubMed]
  41. Ford, J.A. Nonmedical prescription drug use among adolescents: The influence of bonds to family and school. Youth Soc. 2009, 40, 336–352. [Google Scholar] [CrossRef]
  42. McCabe, S.E.; Cranford, J.A.; Morales, M.; Young, A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. J. Stud. Alcohol 2006, 67, 529–537. [Google Scholar] [CrossRef]
  43. McCauley, J.L.; Amstadter, A.B.; Macdonald, A.; Danielson, C.K.; Ruggiero, K.J.; Resnick, H.S.; Kilpatrick, D.G. Non-medical use of prescription drugs in a national sample of college women. Addict. Behav. 2011, 36, 690–695. [Google Scholar] [CrossRef] [Green Version]
  44. Young, A.M.; Glover, N.; Havens, J.R. Nonmedical use of prescription medications among adolescents in the United States: A systematic review. J. Adolesc. Health 2012, 51, 6–17. [Google Scholar] [CrossRef]
  45. Lader, M. Benzodiazepines revisited-will we ever learn? Addiction 2011, 106, 2086–2109. [Google Scholar] [CrossRef]
  46. Compton, W.M.; Volkow, N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006, 83, S4–S7. [Google Scholar] [CrossRef] [PubMed]
  47. Weathermon, R.; Crabb, D.W. Alcohol and medication interactions. Alcohol Res. Health 1999, 23, 40–54. [Google Scholar] [PubMed]
  48. McCauley, J.L.; Danielson, C.K.; Amstadter, A.B.; Ruggiero, K.J.; Resnick, H.S.; Hanson, R.F.; Smith, D.W.; Saunders, B.E.; Kilpatrick, D.G. The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. J. Child Psychol. Psychiatry 2010, 51, 84–93. [Google Scholar] [CrossRef] [PubMed]
  49. Rougemont-Bücking, A.; Grazioli, V.S.; Marmet, S.; Daeppen, J.B.; Lemoine, M.; Gmel, G.; Studera, J. Non-medical use of prescription drugs by young men: Impact of potentially traumatic events and of social-environmental stressors. Eur. J. Psychotraum. 2018, 9, 1468706. [Google Scholar] [CrossRef] [PubMed]
  50. McCabe, S.E.; West, B.; Morales, M.; Cranford, J.; Boyd, C.J. Does Early Onset of non- medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007, 102, 1920–1930. [Google Scholar] [CrossRef] [PubMed]
  51. Fiellin, L.E.; Tetrault, J.M.; Becker, W.C.; Fiellin, D.A.; Hoff, R.A. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. J. Adolesc. Health 2013, 52, 158–163. [Google Scholar] [CrossRef] [PubMed]
  52. Kandel, D.B.; Yamaguchi, K.; Chen, K. Stages of progression in drug involvement from adolescence to adulthood: Further evidence for the gateway theory. J. Stud. Alcohol 1992, 53, 447–457. [Google Scholar] [CrossRef]
  53. Carbia, C.; Corral, M.; García-Moreno, L.M.; Cadaveira, F.; Caamaño-Isorna, F. Early alcohol use and psychopathological symptoms in university students. Psicothema 2016, 28, 247–252. [Google Scholar]
  54. Hingson, R.W.; Heeren, T.; Winter, M.R. Age at drinking onset and alcohol dependence: Age at onset, duration, and severity. Arch. Pediatr. Adolesc. Med. 2006, 160, 739–746. [Google Scholar] [CrossRef]
  55. Hingson, R.W.; Zha, W. Age of drinking onset, alcohol use disorders, frequent heavy drinking, and unintentionally injuring oneself and others after drinking. Pediatrics 2009, 123, 1477–1484. [Google Scholar] [CrossRef]
  56. Borsari, B.; Carey, K.B. Peer influences on college drinking: A review of the research. J. Subst. Abus. 2001, 13, 391–424. [Google Scholar] [CrossRef] [Green Version]
  57. Hu, M.C.; Griesler, P.; Wall, M.; Kandel, D.B. Age-related patterns in nonmedical prescription opioid use and disorder in the us population at ages 12–34 from 2002 to 2014. Drug Alcohol Depend. 2017, 177, 237–243. [Google Scholar] [CrossRef] [PubMed]
  58. Martins, S.S.; Ghandour, L.A. Nonmedical use of prescription drugs in adolescents and young adults: Not just a Western phenomenon. World Psychiatry 2017, 16, 102–104. [Google Scholar] [CrossRef] [PubMed]
  59. Midanik, L.T. Validity of self-reported alcohol use: A literature review and assessment. Br. J. Addict. 1988, 83. [Google Scholar] [CrossRef]
  60. Winters, K.C.; Stinchfield, R.D.; Henly, G.A.; Schwartz, R.H. Validity of adolescent self-report of alcohol and other drug involvement. Int. J. Addict. 1990, 25, 1379–1395. [Google Scholar] [CrossRef] [PubMed]
  61. Rothman, K.J.; Greenland, S.; Lash, T.L. Modern Epidemiology, 3rd ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2008. [Google Scholar]
Figure 1. Trends in non-medical use of prescription drugs (NMUPD) (%) among women who already partook and who did not partake in this type of drug use at the beginning of the study.
Figure 1. Trends in non-medical use of prescription drugs (NMUPD) (%) among women who already partook and who did not partake in this type of drug use at the beginning of the study.
Ijerph 16 02939 g001
Figure 2. Trends in non-medical use of prescription drugs (NMUPD) (%) among men who already partook and who did not partake in this type of drug use at the beginning of the study.
Figure 2. Trends in non-medical use of prescription drugs (NMUPD) (%) among men who already partook and who did not partake in this type of drug use at the beginning of the study.
Ijerph 16 02939 g002
Table 1. Description of the samples at the beginning of the study according to the number of assessments carried out.
Table 1. Description of the samples at the beginning of the study according to the number of assessments carried out.
Percentages
Women (992)Men (371)
1 Time2 Times3 Times 1 Time2 Times3 Times
n = 323n = 344n = 325p-Valuen = 165n = 116n = 90p-Value
Age of onset of alcohol use
After 16 years old21.321.314.5 19.715.618.2
At 16 years old40.439.536.6 32.035.448.1
At 15 years old25.223.728.3 23.119.820.8
Before age of 15 years13.115.820.70.08525.229.213.00.142
Risky consumption51.748.354.80.24161.255.255.60.522
Heavy episodic drinking (%)
Never61.062.560.0 33.941.445.6
Less than once a month20.719.522.5 31.519.821.1
More frequently18.318.017.50.91934.538.833.30.123
Cannabis consumption18.019.218.80.91826.130.224.40.617
Table 2. Prevalence of alcohol, tobacco, and cannabis consumption at the beginning of the study, and at 2-year and 9-year follow-up.
Table 2. Prevalence of alcohol, tobacco, and cannabis consumption at the beginning of the study, and at 2-year and 9-year follow-up.
Percentage or Mean (95%CI)
WomenMen
Initial2-Year9-YearInitial2-Year9-Year
Risky consumption51.552.220.958.062.231.1
Heavy drinking
Never61.256.460.039.134.545.6
Less than once a month20.926.922.525.326.721.1
More frequently17.916.717.535.638.833.4
Cannabis consumption18.616.14.027.019.98.9
Tobacco consumption31.019.416.927.519.410.1
Table 3. Prevalence of non-medical use of prescription drugs at 18, 20, and 27 years old in relation to the substance use profiles of the subjects.
Table 3. Prevalence of non-medical use of prescription drugs at 18, 20, and 27 years old in relation to the substance use profiles of the subjects.
Proportion of Subjects (%)
FemalesMales
at 18 Yearat 20 Yearat 27 Yearat 18 Yearat 20 Yearat 27 Year
Age of onset of use of alcohol
After 16 years old12.219.240.015.510.335.7
At 1617.019.036.616.914.116.2
At 1523.524.743.68.717.131.2
Before the age of 1526.8 *27.645.618.715.840.0
Alcohol risky consumption
No15.818.437.014.716.929.0
Yes21.7 *26.1 *50.5 *15.314.025.0
Heavy drinking
Never16.321.236.215.916.935.1
Less than once a month21.721.748.113.818.222.9
More frequently24.2 *27.743.815.211.222.2
Cannabis use
No17.120.939.714.415.230.5
Yes26.5 *30.6 *38.517.014.6
Tobacco use
No17.721.735.214.112.729.6
Yes21.425.458.2 *17.625.0 *11.1
Total18.922.439.715.115.027.8
* p < 0.05 between categories.
Table 4. Influence of age of onset of alcohol use and substance use in the non-medical use of prescription drugs. Logistic regression.
Table 4. Influence of age of onset of alcohol use and substance use in the non-medical use of prescription drugs. Logistic regression.
Odds Ratio (95% Confidence Interval)
FemalesMales
BivariateMultivariate aBivariate
Age of onset of use of alcohol
Before the age of 15111
At 150.85 (0.62–1.18)0.89 (0.64–1.24)0.66 (0.33–1.32)
At 160.59 (0.43–0.80)0.63 (0.48–0.90)0.81 (0.46–1.45)
After 16 years old0.49 (0.33–0.72)0.66 (0.42–0.94)0.81 (0.40–1.62)
Alcohol risky consumption
No111
Yes1.31 (1.06–1.62)1.43 (1.10–1.86)0.86 (0.57–1.30)
Heavy drinking
Never1 1
Less than once a month1.27 (0.99–1.64) 0.89 (0.54–1.49)
More frequently1.38 (1.04–1.84) 0.75 (0.46–1.22)
Cannabis use
No111
Yes1.48 (1.13–1.93)1.33 (0.99–1.81)0.96 (0.59–1.58)
Tobacco use
No1
Yes1.23 (0.97–1.56) 1.36 (0.85–2.17)
Age of the subjects
18 years-old111
20 years-old1.24 (0.98–1.56)1.19 (0.91–1.55)1.00 (0.62–1.61
27 years-old2.83 (2.16–1.73)3.45 (2.50–4.74)2.16 (1.25–3.73)
a Adjusted by all variables included in the column.

Share and Cite

MDPI and ACS Style

Busto Miramontes, A.; Moure-Rodríguez, L.; Díaz-Geada, A.; Rodríguez-Holguín, S.; Corral, M.; Cadaveira, F.; Caamaño-Isorna, F. Heavy Drinking and Non-Medical Use of Prescription Drugs among University Students: A 9-Year Follow-Up. Int. J. Environ. Res. Public Health 2019, 16, 2939. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph16162939

AMA Style

Busto Miramontes A, Moure-Rodríguez L, Díaz-Geada A, Rodríguez-Holguín S, Corral M, Cadaveira F, Caamaño-Isorna F. Heavy Drinking and Non-Medical Use of Prescription Drugs among University Students: A 9-Year Follow-Up. International Journal of Environmental Research and Public Health. 2019; 16(16):2939. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph16162939

Chicago/Turabian Style

Busto Miramontes, Alicia, Lucía Moure-Rodríguez, Ainara Díaz-Geada, Socorro Rodríguez-Holguín, Montserrat Corral, Fernando Cadaveira, and Francisco Caamaño-Isorna. 2019. "Heavy Drinking and Non-Medical Use of Prescription Drugs among University Students: A 9-Year Follow-Up" International Journal of Environmental Research and Public Health 16, no. 16: 2939. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph16162939

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop